Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.
- DOI
- 10.1136/jitc-2026-015132
- Published
- 2026 Jun 3
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2026-015132,
title = {Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.},
author = {Gujar S and Pol JG and Vijayan VV and Gopalakrishnan Nair P and Babukuttan Sheela U and Banerjee A and Kroemer G},
year = {2026},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2026-015132},
url = {https://doi.org/10.1136/jitc-2026-015132}
}RIS
TY - JOUR TI - Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions. AU - Gujar S AU - Pol JG AU - Vijayan VV AU - Gopalakrishnan Nair P AU - Babukuttan Sheela U AU - Banerjee A AU - Kroemer G PY - 2026 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2026-015132 UR - https://doi.org/10.1136/jitc-2026-015132 ER -
APA
S, G., JG, P., VV, V., P, G. N., U, B. S., A, B., & G, K. (2026). Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-015132
Source records
- pubmed · retrieved 2026-09-25T13:47:42.300Z